St. Clair Advisors’s Gilead Sciences GILD Stock Holding History

St. Clair Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$659K	Hold	5,219	–	–	0.17%	58
2026 Q1	$727K	Hold	5,219	–	–	0.19%	58
2025 Q4	$641K	Hold	5,219	–	–	0.17%	58
2025 Q3	$579K	Hold	5,219	–	–	0.15%	59
2025 Q2	$579K	Hold	5,219	–	–	0.15%	59
2025 Q1	$585K	Hold	5,219	–	–	0.16%	58
2024 Q4	$482K	Hold	5,219	–	–	0.14%	63
2024 Q3	$438K	Hold	5,219	–	–	0.12%	67
2024 Q2	$358K	Hold	5,219	–	–	0.11%	70
2024 Q1	$382K	Hold	5,219	–	–	0.12%	68
2023 Q4	$423K	Sell	5,219 -1,000	-16%	-$77.8K	0.15%	68
2023 Q3	$466K	Hold	6,219	–	–	0.18%	61
2023 Q2	$479K	Buy	6,219 +859	+16%	+$68.5K	0.19%	61
2023 Q1	$445K	Buy	5,360 +3,000	+127%	+$248K	0.19%	60
2022 Q4	$203K	Buy	+2,360	New	+$187K	0.13%	60

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

St. Clair Advisors's GILD Position: Q2 2026 in Review

St. Clair Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 5,219 shares worth $659K. The position accounts for 0.17% of the portfolio, ranked #58.

St. Clair Advisors first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $727K in Q1 2026. 550 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

St. Clair Advisors held 5,219 shares of Gilead Sciences worth $659K as of Q2 2026.
St. Clair Advisors left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.17% of St. Clair Advisors's portfolio in Q2 2026, its #58 holding.
St. Clair Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
St. Clair Advisors's Gilead Sciences position peaked at $727K in Q1 2026.
550 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on St. Clair Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.